{"id":639,"date":"2026-09-29T14:52:39","date_gmt":"2026-09-29T09:22:39","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-29\/"},"modified":"2026-09-29T19:14:12","modified_gmt":"2026-09-29T13:44:12","slug":"mankind-share-price-today-2026-09-29","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-29\/","title":{"rendered":"Mankind Pharma Share Price Rises Today: Why MANKIND Stock is Moving"},"content":{"rendered":"<style>\n      .wt-grid > * { min-width:0; width:100%; }\n      .wt-grid table { width:100%; }\n      .wt-intro { margin:10px 0 16px; line-height:1.55; }\n      .wt-intro strong { white-space:nowrap; }\n      @media (max-width: 760px) {\n        .wt-grid { grid-template-columns:1fr !important; }\n      }\n    <\/style>\n<div style=\"display:flex;flex-wrap:wrap;justify-content:space-between;gap:8px 18px;align-items:center;padding:10px 14px;margin:0 0 14px;background:#f7f9fc;border:1px solid #e1e7ef;border-radius:8px;font-size:13px;line-height:1.45;\">\n      <span><strong>Market Data:<\/strong> 29 Sep 2026 \u2022 03:15 PM IST<\/span><br \/>\n      <span><strong>Status:<\/strong> Automated market-move research draft<\/span>\n    <\/div>\n<div class=\"company-brand\">\n<div class=\"company-details\">\n        <span class=\"company-name\">MANKIND PHARMA LIMITED<\/span><br \/>\n        <span class=\"company-symbol\">MANKIND \u2022 NSE \u2022 F&amp;O Stock<\/span>\n      <\/div>\n<div class=\"company-move up\" style=\"background:#e8f7ef;border:1px solid #bfe3cf;color:#08754f;-webkit-text-fill-color:#08754f;\">+4.49%<\/div>\n<\/p><\/div>\n<p class=\"wt-intro\">MANKIND PHARMA LIMITED traded at <strong>\u20b92,545.00<\/strong>, +4.49% versus the previous close of \u20b92,435.60. <strong>Latest market data: 29 Sep 2026 \u2022 03:15 PM IST.<\/strong><\/p>\n<div style=\"background:#f7fbff;border:1px solid #cfe1f2;border-left:5px solid #2e7db2;border-radius:10px;padding:15px 17px;margin:14px 0 18px;\">\n<div style=\"font-size:15px;font-weight:900;color:#1f4d70;margin-bottom:7px;\">Key Takeaways<\/div>\n<ul style=\"margin:0;padding-left:18px;line-height:1.55;\">\n<li>The stock is +4.49% at \u20b92,545.00.<\/li>\n<li><strong>Likely reason:<\/strong> Stock-specific buying and volume surge<\/li>\n<li>Approximate traded value is <strong>\u20b9500.81 crore<\/strong>.<\/li>\n<li>It is -3.67% from its 52-week high and +33.27% from its 52-week low.<\/li>\n<li>The stock is being compared with <strong>Nifty Pharma<\/strong> alongside the Nifty 50.<\/li>\n<\/ul><\/div>\n<div class=\"market-snapshot\">\n<h2>MANKIND PHARMA LIMITED Share Price Today \u2013 Market Snapshot<\/h2>\n<div style=\"display:grid;grid-template-columns:repeat(5,minmax(0,1fr));gap:10px;margin-top:12px;width:100%;box-sizing:border-box;\">\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Symbol<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">MANKIND<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Date &amp; Time<\/div>\n<div style=\"font-size:14px;font-weight:800;color:#17324d;\">29 Sep 2026 \u2022 03:15 PM IST<\/div>\n<\/div>\n<div style=\"background:#e8f7ef;border:1px solid #bfe3cf;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#08754f;font-weight:800;\">Change<\/div>\n<div style=\"font-size:17px;font-weight:900;color:#08754f;-webkit-text-fill-color:#08754f;\">+4.49%<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Previous Close<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,435.60<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Open<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,440.40<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Day High<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,557.60<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Day Low<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,440.40<\/div>\n<\/div>\n<div style=\"background:#eef5ff;border:1px solid #cdddf4;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#536d91;font-weight:800;\">Price \/ Close<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">\u20b92,545.00<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#607286;font-weight:800;\">Volume<\/div>\n<div style=\"font-size:16px;font-weight:900;color:#17324d;\">1,967,833<\/div>\n<\/div>\n<div style=\"background:#fff7e9;border:1px solid #edd9ad;border-radius:9px;padding:12px;\">\n<div style=\"font-size:11px;text-transform:uppercase;color:#866a32;font-weight:800;\">52-Week Range<\/div>\n<div style=\"font-size:14px;font-weight:900;color:#694d1e;\">\u20b91,909.70 \u2013 \u20b92,642.00<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<h2>Why Is MANKIND PHARMA LIMITED Share Price Rising Today?<\/h2>\n<div class=\"wt-prose\">\n<p>Mankind Pharma Limited shares advanced notably in today&#x27;s session, gaining 4.49% to close at \u20b92,545.00. The stock opened at \u20b92,440.40 and touched an intraday high of \u20b92,557.60, operating near the upper bound of its daily price band. Trading activity spiked significantly, with volume surging to 2.81 times its 5-day average and 4.17 times its 20-day average, accompanied by a healthy delivery percentage of 35.35%.<\/p>\n<p>In relative terms, Mankind Pharma outperformed the broader market and outpaced its sectoral benchmark. While the benchmark Nifty index slipped by 0.28%, the Nifty Pharma sector gained a modest 0.64%, reflecting strong buying interest centered specifically on Mankind against a flat-to-negative broader market backdrop.<\/p>\n<p>On the corporate and news front, the company recently announced the resignation of the statutory auditors of its material wholly-owned subsidiary, Bharat Serums and Vaccines Limited, following earlier board consent for its voluntary liquidation and integration into the parent company. While these administrative restructuring updates provide backdrop context, today&#x27;s sharp price momentum and high trading volume appear primarily driven by strong stock-specific accumulation and buying interest.<\/p>\n<\/div>\n<div style=\"border:1px solid #c9d9e7;border-left:5px solid #1f7b92;border-radius:10px;background:#f5fbfd;padding:16px 18px;margin:16px 0 22px;\">\n<div style=\"display:flex;gap:10px;align-items:center;flex-wrap:wrap;margin-bottom:7px;\">\n<div style=\"font-size:15px;font-weight:900;color:#174c5d;\">Likely Reason for Today&#8217;s Move<\/div>\n<p>        <span style=\"display:inline-block;background:#fff1cf;color:#8a6116;padding:3px 8px;border-radius:999px;font-size:11px;font-weight:900;text-transform:uppercase;\">medium confidence<\/span>\n      <\/div>\n<div style=\"font-size:16px;font-weight:850;color:#20384a;margin-bottom:7px;\">Stock-specific buying and volume surge<\/div>\n<div style=\"line-height:1.58;\">The stock rallied 4.49% on significantly elevated trading volume (over 4x its 20-day average), outperforming both the broader Nifty and Nifty Pharma indices. While recent corporate restructuring updates regarding its subsidiary provide context, the sharp price movement reflects strong underlying buying interest.<\/div>\n<ul style='margin:10px 0 0;padding-left:18px;'>\n<li>Intraday gain of 4.49% with price closing near the day&#x27;s high of \u20b92,557.60<\/li>\n<li>Volume surged to 4.17 times the 20-day average<\/li>\n<li>Outperformed Nifty&#x27;s decline of 0.28% and Nifty Pharma&#x27;s gain of 0.64%<\/li>\n<\/ul><\/div>\n<div style=\"background:linear-gradient(120deg,#123b63,#1d5f82 58%,#0d7a70);border-radius:12px;padding:22px 26px;margin:22px 0 26px;text-align:center;box-shadow:0 8px 20px rgba(25,66,93,.14);width:100%;box-sizing:border-box;\">\n<div style=\"font-size:19px;font-weight:900;color:#fff;-webkit-text-fill-color:#fff;margin-bottom:7px;\">Understand the Move Beyond the Headline<\/div>\n<div style=\"font-size:14px;line-height:1.5;color:#eef8fb;-webkit-text-fill-color:#eef8fb;margin-bottom:13px;\">Explore WittyTrades research across price action, volume, derivatives, company developments and market context.<\/div>\n<p>      <a href=\"https:\/\/www.wittytrades.com\/Segments.html\" style=\"display:inline-block;background:#ffffff;color:#14566d;-webkit-text-fill-color:#14566d;text-decoration:none;font-weight:900;padding:10px 20px;border-radius:6px;\">Explore Research Plans<\/a>\n    <\/div>\n<h2>Performance Context<\/h2>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:repeat(5,minmax(0,1fr));gap:10px;margin:12px 0 22px;\">\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#6b7888;font-weight:800;\">TODAY<\/div>\n<div style=\"font-size:15px;font-weight:900;\">+4.49%<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#6b7888;font-weight:800;\">5 DAYS<\/div>\n<div style=\"font-size:15px;font-weight:900;\">+2.62%<\/div>\n<\/div>\n<div style=\"background:#f8fbfd;border:1px solid #dce5eb;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#6b7888;font-weight:800;\">20 DAYS<\/div>\n<div style=\"font-size:15px;font-weight:900;\">+8.00%<\/div>\n<\/div>\n<div style=\"background:#fff7e9;border:1px solid #edd9ad;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#7a673c;font-weight:800;\">VS 52W HIGH<\/div>\n<div style=\"font-size:15px;font-weight:900;\">-3.67%<\/div>\n<\/div>\n<div style=\"background:#eef8f3;border:1px solid #cbe5d8;border-radius:9px;padding:11px;\">\n<div style=\"font-size:11px;color:#46715d;font-weight:800;\">FROM 52W LOW<\/div>\n<div style=\"font-size:15px;font-weight:900;\">+33.27%<\/div>\n<\/div><\/div>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:1fr 1fr;gap:16px;margin:20px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #b8dfd4;border-radius:12px;background:#eaf8f4;padding:17px;box-sizing:border-box;min-width:0;\">\n<h3 style=\"margin:0 0 4px;color:#155f52;\">Cash-Market Activity<\/h3>\n<div style=\"font-size:12px;color:#5d776f;margin-bottom:10px;\">Latest NSE EOD report: 2026-09-29<\/div>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>Today&#8217;s Volume<\/th>\n<td>1,967,833<\/td>\n<\/tr>\n<tr>\n<th>5-Day Avg. Volume<\/th>\n<td>699,166<\/td>\n<\/tr>\n<tr>\n<th>20-Day Avg. Volume<\/th>\n<td>472,398<\/td>\n<\/tr>\n<tr>\n<th>Volume vs 20-Day Avg.<\/th>\n<td>4.17x<\/td>\n<\/tr>\n<tr>\n<th>Delivery Quantity<\/th>\n<td>697,782<\/td>\n<\/tr>\n<tr>\n<th>Delivery %<\/th>\n<td>35.35%<\/td>\n<\/tr>\n<tr>\n<th>Number of Trades<\/th>\n<td>84,454<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<div style=\"border:1px solid #cec8ef;border-radius:12px;background:#f2efff;padding:17px;box-sizing:border-box;min-width:0;\">\n<h3 style=\"margin:0 0 4px;color:#514694;\">Derivative-Market Activity<\/h3>\n<div style=\"font-size:12px;color:#6e668e;margin-bottom:10px;\">NSE F&amp;O EOD report: 2026-09-28 \u2022 Expiry: 2026-09-29<\/div>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>Near-Month Futures<\/th>\n<td>\u20b92,443.90<\/td>\n<\/tr>\n<tr>\n<th>Cash Reference<\/th>\n<td>\u20b92,435.65<\/td>\n<\/tr>\n<tr>\n<th>Premium \/ Discount<\/th>\n<td>\u20b98.25 (+0.34%)<\/td>\n<\/tr>\n<tr>\n<th>Change in Premium<\/th>\n<td>\u20b910.25<\/td>\n<\/tr>\n<tr>\n<th>Futures Volume<\/th>\n<td>3,991<\/td>\n<\/tr>\n<tr>\n<th>Volume vs Previous Session<\/th>\n<td>0.80x<\/td>\n<\/tr>\n<tr>\n<th>Open Interest<\/th>\n<td>227,750<\/td>\n<\/tr>\n<tr>\n<th>OI vs Previous Session<\/th>\n<td>0.22x<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/p><\/div>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:1fr 1fr;gap:16px;margin:14px 0 22px;width:100%;box-sizing:border-box;\">\n<div style=\"background:#fff5df;border:1px solid #ecd39e;border-left:5px solid #cc922c;border-radius:10px;padding:17px 19px;box-sizing:border-box;min-width:0;\">\n<h3 style=\"margin:0 0 10px;color:#8c6318;\">Promoter Pledge \/ Encumbrance<\/h3>\n<p style=\"margin:0;\">Completion of Realignment of Security Cover in respect of Non-ConvertibleDebentures and Consequent Release of Pledged Shares of Bharat Serums andVaccines Limited<\/p>\n<p style=\"margin:10px 0 0;font-size:12px;color:#7b673d;\">Source: NSE corporate filing<\/p>\n<\/p><\/div>\n<div style=\"background:#f5f8fb;border:1px solid #d5e0ea;border-left:5px solid #6a849c;border-radius:10px;padding:17px 19px;box-sizing:border-box;min-width:0;\">\n<h3 style=\"margin:0 0 10px;color:#405d76;\">Recent Ownership \/ Shareholding Disclosure<\/h3>\n<div style=\"line-height:1.55;\">Promoters and promoter group confirmed that no encumbrances or pledges were created on their shareholdings during the financial year ended March 31, 2026, complying with SEBI takeover regulations.<\/div>\n<ul style='margin:10px 0 0;padding-left:18px;'>\n<li>Promoter group submitted compliance disclosures under Regulation 31(4) of SEBI SAST Regulations confirming zero encumbrances for FY ending March 31, 2026.<\/li>\n<li>Ramesh Juneja, Rajeev Juneja, and Sheetal Arora are listed among the key promoter and promoter group entities.<\/li>\n<\/ul>\n<p style=\"margin:10px 0 0;font-size:12px;color:#647789;\">Source: NSE corporate disclosure. Only factual ownership\/shareholding details extracted from the filing are shown.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"witty-insight\">\n<h3>WittyTrades Data Insight<\/h3>\n<p><strong>Price Position:<\/strong> The stock is near the upper end of the day&#8217;s trading range.<\/p>\n<p><strong>Move From Open:<\/strong> +4.29%.<\/p>\n<p><strong>Intraday Range:<\/strong> 4.81% of the previous close.<\/p>\n<p><strong>5-Day Performance:<\/strong> +2.62%; <strong>20-Day Performance:<\/strong> +8.00%.<\/p>\n<\/p><\/div>\n<div style=\"background:linear-gradient(120deg,#243467,#4a3f8d 58%,#136c74);border-radius:12px;padding:24px 28px;margin:28px 0;text-align:center;box-shadow:0 8px 20px rgba(35,31,89,.16);\">\n<div style=\"font-size:20px;font-weight:900;color:#fff;-webkit-text-fill-color:#fff;margin-bottom:8px;\">Beyond Charts \u2014 Research Backed by Data<\/div>\n<div style=\"font-size:14px;line-height:1.5;color:#f3f1ff;-webkit-text-fill-color:#f3f1ff;margin-bottom:14px;\">Move from market news to structured research using price action, market context, volume behaviour and multiple research inputs.<\/div>\n<p>      <a href=\"https:\/\/www.wittytrades.com\/Segments.html\" style=\"display:inline-block;background:#f2b84b;color:#1f2740;-webkit-text-fill-color:#1f2740;text-decoration:none;font-weight:900;padding:10px 20px;border-radius:6px;\">View Research Segments<\/a>\n    <\/div>\n<h2>Latest Company Developments<\/h2>\n<div style=\"background:#fbfcfe;border:1px solid #e3e9f0;border-radius:12px;padding:14px;margin:12px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-size:15px;font-weight:800;color:#17324d;margin-bottom:4px;\">Resignation of Subsidiary Statutory Auditors<\/div>\n<div style=\"font-size:12px;color:#708090;margin-bottom:6px;\">28-Sep-2026<\/div>\n<div style=\"line-height:1.55;\">Mankind Pharma notified the exchanges regarding the resignation of the statutory auditors of its material wholly-owned subsidiary, Bharat Serums and Vaccines Limited. This follows the board&#x27;s earlier decision to pursue the voluntary liquidation and complete integration of the subsidiary into the parent company.<\/div>\n<div style=\"margin-top:8px;font-size:13px;color:#4f5f6e;\"><strong>Why it matters:<\/strong> Auditor changes in material subsidiaries require monitoring for corporate governance continuity during corporate restructuring.<\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-size:15px;font-weight:800;color:#17324d;margin-bottom:4px;\">Exclusive In-Licensing Agreement for Insulins<\/div>\n<div style=\"font-size:12px;color:#708090;margin-bottom:6px;\">20-Aug-2026<\/div>\n<div style=\"line-height:1.55;\">The company entered into an exclusive in-licensing agreement for Insulin Degludec and Insulin Degludec plus Aspart combination products for the Indian market. This expands Mankind&#x27;s specialized anti-diabetic and chronic care product portfolio.<\/div>\n<div style=\"margin-top:8px;font-size:13px;color:#4f5f6e;\"><strong>Why it matters:<\/strong> Strengthens the company&#x27;s foothold in the high-growth chronic therapeutic segment and expands its branded formulation pipeline.<\/div>\n<\/p><\/div>\n<div style=\"border:1px solid #dce5eb;border-radius:10px;padding:15px 16px;background:#ffffff;margin-bottom:12px;\">\n<div style=\"font-size:15px;font-weight:800;color:#17324d;margin-bottom:4px;\">Approval for Voluntary Liquidation of Subsidiary<\/div>\n<div style=\"font-size:12px;color:#708090;margin-bottom:6px;\">26-Aug-2026<\/div>\n<div style=\"line-height:1.55;\">The board of directors granted formal consent for the integration of Bharat Serums and Vaccines Limited, a material wholly-owned subsidiary, into Mankind Pharma through a voluntary liquidation process.<\/div>\n<div style=\"margin-top:8px;font-size:13px;color:#4f5f6e;\"><strong>Why it matters:<\/strong> Streamlines corporate structure and operational synergies by absorbing a major acquired entity directly into the parent company.<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"wt-grid\" style=\"display:grid;grid-template-columns:1fr 1fr;gap:16px;margin:22px 0 24px;width:100%;box-sizing:border-box;\">\n<div style=\"border:1px solid #c8dfd9;border-radius:12px;padding:17px;background:#f0faf7;box-sizing:border-box;min-width:0;\">\n<h2 style=\"margin-top:0;color:#1d6758;\">Relative Performance<\/h2>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>MANKIND PHARMA LIMITED<\/th>\n<td>+4.49%<\/td>\n<\/tr>\n<tr>\n<th>Nifty 50<\/th>\n<td>-0.28%<\/td>\n<\/tr>\n<tr>\n<th>Nifty Pharma<\/th>\n<td>+0.64%<\/td>\n<\/tr>\n<tr>\n<th>Vs Nifty 50<\/th>\n<td>+4.77%<\/td>\n<\/tr>\n<tr>\n<th>Vs Sector<\/th>\n<td>+3.85%<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<div style=\"border:1px solid #d4cdeb;border-radius:12px;padding:17px;background:#f7f3ff;box-sizing:border-box;min-width:0;\">\n<h2 style=\"margin-top:0;color:#58448a;\">Technical Context<\/h2>\n<table style=\"width:100%;table-layout:fixed;margin:0;\">\n<tbody>\n<tr>\n<th>Price<\/th>\n<td>\u20b92,545.00<\/td>\n<\/tr>\n<tr>\n<th>Day High \/ Low<\/th>\n<td>\u20b92,557.60 \/ \u20b92,440.40<\/td>\n<\/tr>\n<tr>\n<th>52-Week High<\/th>\n<td>\u20b92,642.00<\/td>\n<\/tr>\n<tr>\n<th>52-Week Low<\/th>\n<td>\u20b91,909.70<\/td>\n<\/tr>\n<tr>\n<th>5-Day Return<\/th>\n<td>+2.62%<\/td>\n<\/tr>\n<tr>\n<th>20-Day Return<\/th>\n<td>+8.00%<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/p><\/div>\n<h2>What Should Traders and Investors Watch Next?<\/h2>\n<ul>\n<li>Progress and regulatory approvals regarding the voluntary liquidation and integration of Bharat Serums and Vaccines Limited<\/li>\n<li>Commercialization updates on the newly in-licensed insulin products in the anti-diabetic segment<\/li>\n<li>Sustained delivery volumes and price stability above key moving averages<\/li>\n<li>Upcoming financial results and management commentary on chronic therapy margins<\/li>\n<\/ul>\n<div style=\"background:linear-gradient(120deg,#123c35,#176654 62%,#0d8368);border-radius:12px;padding:23px 28px;margin:28px 0;text-align:center;box-shadow:0 8px 20px rgba(17,80,63,.15);\">\n<div style=\"font-size:19px;font-weight:900;color:#fff;-webkit-text-fill-color:#fff;margin-bottom:8px;\">Get Research-Backed Market Opportunities<\/div>\n<div style=\"font-size:14px;line-height:1.5;color:#effbf6;-webkit-text-fill-color:#effbf6;margin-bottom:14px;\">Explore WittyTrades research segments for trading, swing and investment ideas.<\/div>\n<p>      <a href=\"https:\/\/www.wittytrades.com\/Segments.html\" style=\"display:inline-block;background:#fff;color:#0b6d55;-webkit-text-fill-color:#0b6d55;text-decoration:none;font-weight:900;padding:10px 20px;border-radius:6px;\">Get Research-Backed Recommendations<\/a>\n    <\/div>\n<p style=\"background:#f8fafc;border:1px solid #dce5eb;border-left:4px solid #6b7d90;border-radius:9px;padding:14px 16px;\">\n      <strong>Catalyst note:<\/strong> No single same-day catalyst was officially announced to directly trigger today&#x27;s surge, which appears driven by strong institutional or retail accumulation and volume expansion.\n    <\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the likely reason for today&#8217;s move?<\/h3>\n<p>The stock rallied 4.49% on significantly elevated trading volume (over 4x its 20-day average), outperforming both the broader Nifty and Nifty Pharma indices. While recent corporate restructuring updates regarding its subsidiary provide context, the sharp price movement reflects strong underlying buying interest.<\/p>\n<h3>Is trading volume elevated?<\/h3>\n<p>Today&#8217;s volume is 1,967,833. The latest 20-day average available is 472,398, equivalent to about 4.17x of the recent average.<\/p>\n<h3>What does the derivatives market show?<\/h3>\n<p>The latest official NSE F&#038;O report is summarised in the Derivative-Market Activity box above.<\/p>\n<h3>Before acting on this stock<\/h3>\n<p>Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the <a href=\"https:\/\/www.wittytrades.com\/Segments.html\"><strong>WittyTrades subscription plans and research segments<\/strong><\/a>.<\/p>\n<div class=\"witty-related\">\n<h2>More Market News from WittyTrades<\/h2>\n<ul style=\"margin:0 0 10px;padding-left:18px;\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/glenmark-share-price-today-2026-09-29\/\">Glenmark Pharma Shares Surge 5%: Why Glenmark Stock is Rising Today<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/drreddy-share-price-today-2026-09-29\/\">Dr. Reddy&#x27;s Lab Shares Rise: Why DRREDDY Stock is Moving Today<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/apollohosp-share-price-today-2026-09-29\/\">Why Apollo Hospitals Share Price Fell 2.27% Today<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sagility-share-price-today-2026-09-29\/\">Sagility Share Price Falls 2% Today: Key Factors &amp; Analysis<\/a><\/li>\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/policybzr-share-price-today-2026-09-29\/\">Why PB Fintech Share Price Fell Today | Policybazaar Stock News<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/\">View Latest Market News \u2192<\/a><\/p>\n<\/p><\/div>\n<div style=\"background:#f8fafc;border:1px solid #dfe6ed;border-radius:9px;padding:14px 16px;margin:18px 0;\">\n      <strong>Source &amp; methodology:<\/strong><br \/>\n      Market data, exchange filings, company disclosures and reputable business-media reports are collected automatically and summarised for investor context. Material facts are cross-checked where possible; price data may be delayed and a cited development should not be assumed to be the sole cause of a market move unless the evidence supports that conclusion.\n    <\/div>\n<p><strong>Article by:<\/strong> WittyTrades Research Desk<\/p>\n<div class=\"witty-disclaimer\">\n      <strong>Disclaimer:<\/strong><br \/>\n      Investments in securities markets are subject to market risks. Read all related documents carefully before investing.<br \/>\n      Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors.<br \/>\n      This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security.<br \/>\n      Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions.\n    <\/div>\n<p>    <script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"headline\": \"Mankind Pharma Share Price Rises Today: Why MANKIND Stock is Moving\", \"description\": \"Mankind Pharma shares jumped 4.49% on heavy trading volume. Read our analysis on the price action, relative sector performance, and recent developments.\", \"datePublished\": \"2026-09-29T09:22:39Z\", \"dateModified\": \"2026-09-29T19:14:07.229652+05:30\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"about\": {\"@type\": \"Corporation\", \"name\": \"MANKIND PHARMA LIMITED\", \"tickerSymbol\": \"MANKIND\"}, \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-29\/\"}, \"url\": \"https:\/\/www.wittytrades.com\/market-news\/mankind-share-price-today-2026-09-29\/\", \"keywords\": [\"why Mankind Pharma share price is rising today\", \"Mankind Pharma stock news\", \"MANKIND share price analysis\", \"Mankind Pharma volume surge\", \"Mankind Pharma latest updates\"]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mankind Pharma shares jumped 4.49% on heavy trading volume. Read our analysis on the price action, relative sector performance, and recent developments.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Mankind Pharma Share Price Rises Today: Why MANKIND Stock is Moving","_witty_meta_description":"Mankind Pharma shares jumped 4.49% on heavy trading volume. Read our analysis on the price action, relative sector performance, and recent developments.","_witty_primary_phrase":"why Mankind Pharma share price is rising today","_witty_reason_label":"Stock-specific buying and volume surge","_witty_reason_confidence":"medium","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[],"class_list":["post-639","post","type-post","status-publish","format-standard","hentry","category-market-movers","category-stocks-in-news"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=639"}],"version-history":[{"count":2,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/639\/revisions"}],"predecessor-version":[{"id":727,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/639\/revisions\/727"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}